ZoomMed Stock Forecast, Price & News

+0.02 (+∞)
(As of 10/4/2018)
Today's Range
50-Day Range
52-Week Range
Volume220,000 shs
Average Volume290,486 shs
Market CapitalizationC$2.03 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ZMD News and Ratings via Email

Sign-up to receive the latest news and ratings for ZoomMed and its competitors with MarketBeat's FREE daily newsletter.

About ZoomMed

ZoomMed Inc., together with its subsidiaries, develops and markets a range of computer applications designed for healthcare professionals primarily in the United States and the United Kingdom. The company builds and operates a clinical information exchange platform between physicians, pharmacists, and various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical companies, laboratories, physiotherapy clinics, and other organizations. It also offers ZRx Prescriber, a technological Web application that enables physicians to generate prescriptions. ZoomMed Inc. was incorporated in 2005 and is headquartered in Brossard, Canada.


No headlines for this company have been tracked by

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.44 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

ZoomMed (CVE:ZMD) Frequently Asked Questions

What stocks does MarketBeat like better than ZoomMed?

Wall Street analysts have given ZoomMed a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ZoomMed wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are ZoomMed's key executives?

ZoomMed's management team includes the following people:
  • Mr. Yves Marmet, Chairman, CEO & Pres
  • Ms. Marie-Helene Pinard, CFO, VP of Operations & Fin., Sec. and Director
  • Mr. André Marmet, VP of Corp. Bus.

Who are some of ZoomMed's key competitors?

What is ZoomMed's stock symbol?

ZoomMed trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ZMD."

How do I buy shares of ZoomMed?

Shares of ZMD and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is ZoomMed's stock price today?

One share of ZMD stock can currently be purchased for approximately C$0.02.

How much money does ZoomMed make?

ZoomMed has a market capitalization of C$2.03 million and generates C$10,000.00 in revenue each year.

What is ZoomMed's official website?

The official website for ZoomMed is

Where are ZoomMed's headquarters?

ZoomMed is headquartered at 8005 du Quartier Blvd Suite 303, BROSSARD, QC J4Y 0N5, Canada.

How can I contact ZoomMed?

ZoomMed's mailing address is 8005 du Quartier Blvd Suite 303, BROSSARD, QC J4Y 0N5, Canada. The company can be reached via phone at +1-450-6785457.

This page was last updated on 6/14/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.